Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence

Psychology of Addictive Behaviors

Volumn 29, Issue 1, 2015, Pages 237-246

  Rass, Olga ^a   Umbricht, Annie ^a   Bigelow, George E ^a   Strain, Eric C ^a   Johnson, Matthew W ^a   Mintzer, Miriam Z ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cocaine; Cognition; Methadone maintenance; Substance dependence; Topiramate

Indexed keywords

METHADONE; PLACEBO; TOPIRAMATE; FRUCTOSE;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COCAINE DEPENDENCE; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDUCATION; EPISODIC MEMORY; FEMALE; HUMAN; INFORMATION PROCESSING; INTELLIGENCE QUOTIENT; MALE; MENTAL PERFORMANCE; MENTAL TASK; OUTPATIENT; PSYCHOMOTOR ACTIVITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF CONTROL; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT RESPONSE; WORKING MEMORY; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; COMBINATION DRUG THERAPY; FOLLOW UP; NEUROPSYCHOLOGICAL TEST; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY;

ADULT; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; DIAGNOSIS, DUAL (PSYCHIATRY); DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; METHADONE; NEUROPSYCHOLOGICAL TESTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS;

EID: 84945196926     PISSN: 0893164X     EISSN: 19391501     Source Type: Journal    
DOI: 10.1037/adb0000027     Document Type: Article

References (65)

1. Anthenelli, R. M., Blom, T. J., McElroy, S. L., & Keck, P. E., Jr. (2008). Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation. Addiction, 103, 687-694. doi: 10.1111/j.1360-0443.2008.02148.x
2. Baker, F., Johnson, M. W., & Bickel, W. K. (2003). Delay discounting in current and never-before cigarette smokers: Similarities and differences across commodity, sign, and magnitude. Journal of Abnormal Psychology, 112, 382-392. doi:10.1037/0021-843X.112.3.382
3. Baltieri, D. A., Daro, F. R., Ribeiro, P. L., & de Andrade, A. G. (2008). Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction, 103, 2035-2044. doi:10.1111/j.1360-0443.2008.02355.x
4. Barrett, A. C., Negus, S. S., Mello, N. K., & Caine, S. B. (2005). Effect of GABA agonists and GABA-A receptor modulators on cocaine-and food-maintained responding and cocaine discrimination in rats. The Journal of Pharmacology and Experimental Therapeutics, 315, 858-871. doi:10.1124/jpet.105.086033
5. Bechara, A., Damasio, A. R., Damasio, H., & Anderson, S. W. (1994). Insensitivity to future consequences following damage to human pre-frontal cortex. Cognition, 50, 7-15. doi:10.1016/0010-0277(94)90018-3
6. Berlin, H. A., Koran, L. M., Jenike, M. A., Shapira, N. A., Chaplin, W., Pallanti, S., & Hollander, E. (2011). Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. Journal of Clinical Psychiatry, 72, 716-721. doi: 10.4088/JCP.09m05266gre
7. Beveridge, T. J., Gill, K. E., Hanlon, C. A., & Porrino, L. J. (2008). Review. Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys. Philosophical Transactions of the Royal Society of London, 363, 3257-3266. doi:10.1098/rstb.2008.0102
8. Bootsma, H. P., Ricker, L., Hekster, Y. A., Hulsman, J., Lambrechts, D., Majoie, M.,.. Aldenkamp, A. P. (2009). The impact of side effects on long-term retention in three new antiepileptic drugs. Seizure, 18, 327-331. doi:10.1016/j.seizure.2008.11.006
9. Brecht, M. L., O'Brien, A., von Mayrhauser, C., & Anglin, M. D. (2004). Methamphetamine use behaviors and gender differences. Addictive Behaviors, 29, 89-106. doi:10.1016/S0306-4603(03)00082-0
10. Cretzmeyer, M., Sarrazin, M. V., Huber, D. L., Block, R. I., & Hall, J. A. (2003). Treatment of methamphetamine abuse: Research findings and clinical directions. Journal of Substance Abuse Treatment, 24, 267-277. doi:10.1016/S0740-5472(03)00028-X
11. Dakwar, E., Levin, F., Foltin, R. W., Nunes, E. V., & Hart, C. L. (2014). The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers. Biological Psychiatry, 76, 40-46. doi:10.1016/j.biopsych.2013.08.009
12. Dobler-Mikola, A., Hattenschwiler, J., Meili, D., Beck, T., Boni, E., & Modestin, J. (2005). Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. Journal of Substance Abuse Treatment, 29, 259-265. doi:10.1016/j.jsat.2005.08.002
13. Eddy, C. M., Rickards, H. E., & Cavanna, A. E. (2011). The cognitive impact of antiepileptic drugs. Therapeutic Advances in Neurological Disorders, 4, 385-407. doi:10.1177/1756285611417920
14. Elkashef, A., Kahn, R., Yu, E., Iturriaga, E., Li, S. H., Anderson, A.,.. Johnson, B. A. (2012). Topiramate for the treatment of methamphet-amine addiction: A multi-center placebo-controlled trial. Addiction, 107, 1297-1306. doi:10.1111/j.1360-0443.2011.03771.x
15. Fein, G., & Di Sclafani, V. (2004). Cerebral reserve capacity: Implications for alcohol and drug abuse. Alcohol, 32, 63-67. doi:10.1016/j.alcohol.2003.10.003
16. Goodman, L. A., & Kruskal, W. H. (1954). Measures of association for cross classifications. Journal of the American Statistical Association, 49, 732-764. doi:10.2307/2281536
17. Griffiths, R. R., Bigelow, G. E., & Liebson, I. (1983). Differential effects of diazepam and pentobarbital on mood and behavior. Archives of General Psychiatry, 40, 865-873. doi:10.1001/archpsyc.1983.01790070055007
18. Ivanov, I., Schulz, K. P., London, E. D., & Newcorn, J. H. (2008). Inhibitory control deficits in childhood and risk for substance use disorders: A review. The American Journal of Drug and Alcohol Abuse, 34, 239-258. doi:10.1080/00952990802013334
19. Johnson, B. A., Ait-Daoud, N., Wang, X. Q., Penberthy, J. K., Javors, M. A., Seneviratne, C., & Liu, L. (2013). Topiramate for the treatment of cocaine addiction: A randomized clinical trial. Journal of the American Medical Association Psychiatry, 70, 1338-1346. doi:10.1001/jamapsychiatry.2013.2295
20. Johnson, B. A., Roache, J. D., Ait-Daoud, N., Wells, L. T., Wallace, C. L., Dawes, M. A.,.. Wang, X. Q. (2007). Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 123-130. doi:10.1016/j.pnpbp.2006.08.002
21. Johnson, B. A., Rosenthal, N., Capece, J. A., Wiegand, F., Mao, L., Beyers, K.,.. Swift, R. M. (2007). Topiramate for treating alcohol dependence: A randomized controlled trial. JAMA: The Journal of the American Medical Association, 298, 1641-1651. doi:10.1001/jama.298.14.1641
22. Johnson, M. W., & Bickel, W. K. (2002). Within-subject comparison of real and hypothetical money rewards in delay discounting. Journal of the Experimental Analysis of Behavior, 77, 129-146. doi:10.1901/jeab.2002.77-129
23. Jonides, J., Schumacher, E. H., Smith, E. E., Lauber, E. J., Awh, E., Minoshima, S., & Koeppe, R. A. (1997). Verbal working memory load affects regional brain activation as measured by PET. Journal of Cognitive Neuroscience, 9, 462-475. doi:10.1162/jocn.1997.9.4.462
24. Kalivas, P. W. (2004). Glutamate systems in cocaine addiction. Current Opinion in Pharmacology, 4, 23-29. doi:10.1016/j.coph.2003.11.002
25. Kampman, K. M., Pettinati, H., Lynch, K. G., Dackis, C., Sparkman, T., Weigley, C., & O'Brien, C. P. (2004). A pilot trial of topiramate for the treatment of cocaine dependence. Drug and Alcohol Dependence, 75, 233-240. doi:10.1016/j.drugalcdep.2004.03.008
26. Kampman, K. M., Pettinati, H. M., Lynch, K. G., Spratt, K., Wierzbicki, M. R., & O'Brien, C. P. (2013). A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug and Alcohol Dependence, 133, 94-99. doi:10.1016/j.drugalcdep.2013.05.026
27. Kampman, K. M., Volpicelli, J. R., McGinnis, D. E., Alterman, A. I., Weinrieb, R. M., D'Angelo, L., & Epperson, L. E. (1998). Reliability and validity of the Cocaine Selective Severity Assessment. Addictive Behaviors, 23, 449-461. doi:10.1016/S0306-4603(98)00011-2
28. Keppel, G. (1991). Design and analysis: A researcher's handbook (3rd ed.). Englewood Cliffs, NJ: Prentice Hall.
29. Kleykamp, B. A., Griffiths, R. R., & Mintzer, M. Z. (2010). Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers. Experimental and Clinical Psychopharmacology, 18, 1-16. doi:10.1037/a0018407
30. Kockelmann, E., Elger, C. E., & Helmstaedter, C. (2003). Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Research, 54, 171-178. doi:10.1016/S0920-1211(03)00078-0
31. Kushner, S. F., Khan, A., Lane, R., & Olson, W. H. (2006). Topiramate monotherapy in the management of acute mania: Results of four double-blind placebo-controlled trials. Bipolar Disorders, 8, 15-27. doi: 10.1111/j.1399-5618.2006.00276.x
32. Lee, H. W., Jung, D. K., Suh, C. K., Kwon, S. H., & Park, S. P. (2006). Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up. Epilepsy & Behavior, 8, 736-741. doi: 10.1016/j.yebeh.2006.03.006
33. Loring, D. W., Williamson, D. J., Meador, K. J., Wiegand, F., & Hulihan, J. (2011). Topiramate dose effects on cognition: A randomized double-blind study. Neurology, 76, 131-137. doi:10.1212/WNL.0b013e318206ca02
34. Lundqvist, T. (2010). Imaging cognitive deficits in drug abuse. Current Topics in Behavioral Neurosciences, 3, 247-275. doi:10.1007/7854-2009-26
35. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G.,.. Argeriou, M. (1992). The fifth edition of the Addiction Severity Index. The Journal of Substance Abuse Treatment, 9, 199-213.
36. McLeod, D. R., Bigelow, G. E., & Liebson, I. A. (1982). Self-regulated opioid detoxification by humans: Effects of methadone pretreatment. NIDA Research Monograph, 41, 232-238.
37. Meador, K. J., Loring, D. W., Vahle, V. J., Ray, P. G., Werz, M. A., Fessler, A. J.,.. Kustra, R. P. (2005). Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology, 64, 2108-2114. doi:10.1212/01.WNL.0000165994.46777.BE
38. Mills, K. C., Drazkowski, J. F., Hammer, A. E., Caldwell, P. T., Kustra, R. P., & Blum, D. E. (2008). Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view. Epilepsy Research, 78, 140-146. doi:10.1016/j.eplepsyres.2007.10.013
39. Mintzer, I. L., Eisenberg, M., Terra, M., MacVane, C., Himmelstein, D. U., & Woolhandler, S. (2007). Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Annals of Family Medicine, 5, 146-150. doi:10.1370/afm.665
40. Mintzer, M. Z., Frey, J. M., Yingling, J. E., & Griffiths, R. R. (1997). Triazolam and zolpidem: A comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers. Behavioural Pharmacology, 8, 561-574. doi:10.1097/00008877-199711000-00014
41. Mintzer, M. Z., & Griffiths, R. R. (2007). A triazolam/amphetamine dose-effect interaction study: Dissociation of effects on memory versus arousal. Psychopharmacology (Berl), 192, 425-440. doi:10.1007/s00213-007-0726-y
42. Mintzer, M. Z., & Stitzer, M. L. (2002). Cognitive impairment in metha-done maintenance patients. Drug and Alcohol Dependence, 67, 41-51. doi:10.1016/S0376-8716(02)00013-3
43. Myerson, J., Green, L., & Warusawitharana, M. (2001). Area under the curve as a measure of discounting. Journal of the Experimental Analysis of Behavior, 76, 235-243. doi:10.1901/jeab.2001.76-235
44. Park, S. P., & Kwon, S. H. (2008). Cognitive effects of antiepileptic drugs. Journal of Clinical Neurology, 4, 99-106. doi:10.3988/jcn.2008.4.3.99
45. Reas, D. L., & Grilo, C. M. (2014). Current and emerging drug treatments for binge eating disorder. Expert Opinion on Emerging Drugs, 19, 99-142. doi:10.1517/14728214.2014.879291
46. Reitan, R., & Wolfson, D. (1993). The Halstead-Reitan neuropsycholog-ical test battery: Theory and clinical interpretation. Tucson, AZ: Neu-ropsychology Press.
47. Romigi, A., Cervellino, A., Marciani, M. G., Izzi, F., Massoud, R., Corona, M.,.. Placidi, F. (2008). Cognitive and psychiatric effects of topira-mate monotherapy in migraine treatment: An open study. European Journal of Neurology, 15, 190-195. doi:10.1111/j.1468-1331.2007.02033.x
48. Salinsky, M. C., Storzbach, D., Spencer, D. C., Oken, B. S., Landry, T., & Dodrill, C. B. (2005). Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology, 64, 792-798. doi:10.1212/01.WNL.0000152877.08088.87
49. Shinn, A. K., & Greenfield, S. F. (2010). Topiramate in the treatment of substance-related disorders: A critical review of the literature. Journal of Clinical Psychiatry, 71, 634-648. doi:10.4088/JCP.08r04062gry
50. Simonson, E., & Brozek, J. (1952). Flicker fusion frequency; Background and applications. Physiological Reviews, 32, 349-378.
51. Snodgrass, J. G., & Corwin, J. (1988). Pragmatics of measuring recognition memory: Applications to dementia and amnesia. Journal of Experimental Psychology: General, 117, 34-50. doi:10.1037/0096-3445.117.1.34
52. Sommer, B. R., Mitchell, E. L., & Wroolie, T. E. (2013). Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity. Therapeutic Advances in Neurological Disorders, 6, 211-227. doi:10.1177/1756285613481257
53. Sternberg, S. (1969). The discovery of processing stages: Extensions of Donders' method. ACTA Psychologica, 30, 276-315. doi:10.1016/0001-6918(69)90055-9
54. Thompson, P. J., Baxendale, S. A., Duncan, J. S., & Sander, J. W. (2000). Effects of topiramate on cognitive function. Journal of Neurology, Neurosurgery & Psychiatry, 69, 636-641. doi:10.1016/j.drugalcdep.2014.03.033
55. Umbricht, A., DeFulio, A., Winstanley, E. L., Tompkins, D. A., Peirce, J., Mintzer, M. Z.,.. Bigelow, G. E. (2014). Topiramate for cocaine dependence during methadone maintenance treatment: A randomized controlled trial. Drug and Alcohol Dependence, 140, 92-100. doi: 10.1016/j.drugalcdep.2014.03.033
56. Vandrey, R. G., & Mintzer, M. Z. (2009). Performance and cognitive alterations. In L. Cohen, F. L. Collins, A. M. Young, D. E. McChargue & T. R. Leffingwell (Eds.), The pharmacology and treatment of substance abuse: An evidence-based approach. Mahwah, NJ: Erlbaum, Inc.
57. von Mayrhauser, C., Brecht, M. L., & Anglin, M. D. (2001). Use ecology and drug use motivations of methamphetamine users admitted to substance abuse treatment facilities in Los Angeles: An emerging profile. Journal of Addictive Diseases, 21, 45-60. doi:10.1300/J069v21n01-05
58. Watts, B. V., Schnurr, P. P., Mayo, L., Young-Xu, Y., Weeks, W. B., & Friedman, M. J. (2013). Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. Journal of Clinical Psychiatry, 74, e541-550. doi:10.4088/JCP.12r08225
59. Wechsler, D. (1997). WAIS-III: Administration and scoring manual: Wechsler Adult Intelligence Scale, 3rd ed. San Antonio, TX: Psychological Corporation.
60. Weerts, E. M., Froestl, W., & Griffiths, R. R. (2005). Effects of GABAe-rgic modulators on food and cocaine self-administration in baboons. Drug and Alcohol Dependence, 80, 369-376. doi:10.1016/j.drugalcdep.2005.05.006
61. Yücel, M., Lubman, D. I., Solowij, N., & Brewer, W. J. (2007). Understanding drug addiction: A neuropsychological perspective. Australian and New Zealand Journal of Psychiatry, 41, 957-968. doi:10.1080/00048670701689444
62. Zachary, R. A., Paulson, M. J., & Gorsuch, R. L. (1985). Estimating WAIS IQ from the Shipley Institute of Living Scale using continuously adjusted age norms. Journal of Clinical Psychology, 41, 820-831. doi:10.1002/1097-4679(198511)41:63.0.CO;2-X
63. Zacny, J. P. (1995). A review of the effects of opioids on psychomotor and cognitive functioning in humans. Experimental and Clinical Psychopharmacology 3, 432-466. doi:10.1037/1064-1297.3.4.432
64. Zullino, D. F., Cottier, A. C, & Besson, J. (2002). Topiramate in opioid withdrawal. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26, 1221-1223. doi:10.1016/S0278-5846(02)00251-8
65. Zullino, D. F., Krenz, S., Zimmerman, G., Miozzari, A., Rajeswaran, R., Kolly, S., & Khazaal, Y. (2005). Topiramate in opioid withdrawalcomparison with clonidine and with carbamazepine/mianserin. Substance Abuse, 25, 27-33. doi:10.1300/J465v25n04-04